PKPD Exam 3 Flashcards
bioavailability of digoxin tablets
f = 0.7
bioavailability of digoxin elixir
f = 0.8
bioavailability of digoxin lanoxicaps
f = 1
average volume of digoxin
7.3 L/kg
therapeutic range (css,av) for digoxin
0.5-2.0 ng/mL (mcg/L)
why is pk optimization needed for digoxin
-high interpatient variability in disposition
-low TI
-poor accuracy in predicting PK parameters from patient characteristics
after how many hours are collected digoxin concentrations considered the Css,av concentration
6 hours
what is the specific activity of anti-digoxin immune fab
0.8
why is there a maximum infusion rate for phenytoin sodium
avoid hypotension due to cardiac suppression
what is the water soluble ester prodrug of phenytoin that avoids injection problems and can be administered more rapidly
fosphenytoin
why is IM phenytoin sodium not recommended
some precipitates resulting in prolonged erratic absorption, painful
phenytoin is a weak acid with limited water solubility, so absorption is…..
slow, peaks delayed several hours
phenytoin is primarily bound to
albumin in the plasma
concentrations of phenytoin needed to be adjusted to account for
altered protein binding
ESRD
which drug displaces phenytoin from plasma albumin and needs to be considered to adjust concentration
valproate
how is phenytoin primarily cleared
hepatic metabolism by CYP2C9
what type of PK does phenytoin follow
nonlinear–> number of drug saturates the enzymes ability to metabolize the drug
therapeutic range of phenytoin
10-20 mg/L of total phenytoin
what is the Vd of phenytoin (estimated before data)
0.65 L/kg
what is the Vmax of phenytoin (estimated before data)
7 mg/kg/day